Bertes, Resneal D.

HRN: 23-07-37  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
CEFUROXIME 1.5GM (VIAL)
07/03/2026
07/09/2026
IVT
500mg
Q8
Dengue Shock Syndrome
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: